Exploring the Diversity of Visceral, Subcutaneous and Perivascular Adipose Tissue in a Vascular Surgery Population
- PMID: 37504527
- PMCID: PMC10380901
- DOI: 10.3390/jcdd10070271
Exploring the Diversity of Visceral, Subcutaneous and Perivascular Adipose Tissue in a Vascular Surgery Population
Abstract
The prevalence of obesity has doubled, with a concomitant increase in cardiovascular disease. This study aimed to compare the characteristics of visceral, subcutaneous and peri-aortic adipose tissue determined with computed tomography (CT) scans and to correlate them with cardiovascular risk factors, anthropometric measures and medication. An observational and prospective study was conducted, and 177 subjects were included. Peri-aortic adipose tissue had the highest density, while the subcutaneous adipose tissue had the lowest. The density of subcutaneous adipose tissue differs from the density of visceral (p = 0.00) and peri-aortic adipose tissue (p = 0.00). Smokers/ex-smokers had a lower area (p = 0.00) and density (p = 0.02) of subcutaneous adipose tissue. Multiple linear regression analysis showed that sex was a predictor of subcutaneous adipose tissue area (β = -0.27, t = -3.12, p = 0.00) but smoking habits were not. After controlling for sex, we found that the association between smokers/ex-smokers and area of subcutaneous adipose tissue was lost, but the association with density persisted. Patients with hypertension had a higher visceral adipose tissue area, and this relationship was maintained even after adjusting for gender. Peri-aortic adipose tissue is similar to visceral and distinct from subcutaneous adipose tissue. Cardiovascular risk factors have different influences in distinct adipose compartments.
Keywords: adipose tissue; angiotensin receptor antagonist; angiotensin-converting-enzyme inhibitors; cardiovascular risk factors; inflammation; statins.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Ahmadieh S., Kim H.W., Weintraub N.L. Potential role of perivascular adipose tissue in modulating atherosclerosis. [(accessed on 11 January 2023)];Clin. Sci. 2020 134:3–13. doi: 10.1042/CS20190577. Available online: https://portlandpress.com/clinsci/article/134/1/3/221757/Potential-role-.... - DOI - PMC - PubMed
-
- Powell-Wiley T.M., Poirier P., Burke L.E., Després J.-P., Gordon-Larsen P., Lavie C.J., Lear S.A., Ndumele C.E., Neeland I.J., Sanders P., et al. Obesity and Cardiovascular Disease: A Scientific Statement from the American Heart Association. Circulation. 2021;143:e984–e1010. doi: 10.1161/CIR.0000000000000973. - DOI - PMC - PubMed
-
- The World Obesity Federation Projections of Obesity Prevalence in 2030. World Obes. Atlas. 2022;2022:18–41.
-
- Fadini G.P., Boscaro E., de Kreutzenberg S., Agostini C., Seeger F., Dimmeler S., Zeiher A., Tiengo A., Avogaro A. Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes. Diabetes Care. 2010;33:1097–1102. doi: 10.2337/dc09-1999. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
